Loading…

Combination of retrograde superselective intra-arterial chemotherapy and Seldinger method in locally advanced oral cancer

The nonsurgical strategies for locally advanced oral cancer are desirable. Superselective intra-arterial infusion with radiotherapy was utilized for this purpose, and there are two types of superselective intra-arterial infusion methods: The Seldinger method and the retrograde superselective intra-a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cancer research and therapeutics 2015-04, Vol.11 (2), p.475-478
Main Authors: Uehara, Masataka, Ohya, Ryouichi, Kodama, Masaaki, Shiraishi, Takeshi, Asahina, Izumi, Tominaga, Kazuhiro
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 478
container_issue 2
container_start_page 475
container_title Journal of cancer research and therapeutics
container_volume 11
creator Uehara, Masataka
Ohya, Ryouichi
Kodama, Masaaki
Shiraishi, Takeshi
Asahina, Izumi
Tominaga, Kazuhiro
description The nonsurgical strategies for locally advanced oral cancer are desirable. Superselective intra-arterial infusion with radiotherapy was utilized for this purpose, and there are two types of superselective intra-arterial infusion methods: The Seldinger method and the retrograde superselective intra-arterial chemotherapy (HFT method). In one case, the HFT method was applied to locally advanced tongue cancer, and the Seldinger method was used for additional administration of cisplatin (CDDP) to compensate for a lack of drug flow in the HFT method. In another case, the HFT method was applied to locally advanced lower gingival cancer. The Seldinger method was applied to metastatic lymph nodes. In both cases, additional administration of CDDP using the Seldinger method resulted in a complete response. The combination of the HFT and Seldinger methods was useful to eradicate locally advanced oral cancer because each method compensated for the defects of the other.
doi_str_mv 10.4103/0973-1482.140833
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1694961615</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A421598531</galeid><sourcerecordid>A421598531</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-1845b481332c0424d93219a35cb7e3a725061eaff51efa88c1666d10d29729723</originalsourceid><addsrcrecordid>eNptkk2LHCEQhiUkZCeb3HMKQi659MSvtvW4DJsPWMghyVkcrZ5xsXWiPQvz72Mzmw0Jg4JS9byFVr0IvaVkLSjhH4keeEeFYmsqiOL8GVpRrVUnKFfP0eopfYVe1XpPSD8wpl6iKyZbVDK2QqdNnrYh2TnkhPOIC8wl74r1gOvxAKVCBDeHB8AhzcV2tsxQgo3Y7WHK8x6KPZywTR5_h-hD2kHBE8z77JsAx-xsjC3vH2xy4HEui3S5l9foxWhjhTeP5zX6-en2x-ZLd_ft89fNzV3nBBvmjirRb4WinDNHBBNec0a15b3bDsDtwHoiKdhx7CmMVilHpZSeEs_0sGx-jT6c6x5K_nWEOpspVAcx2gT5WA2VWmhJJe0b-v4_9D4fS2qvWygple4J-UvtbAQT0phbY9xS1NwIRnutek4b1V2gdpBax2JOMIYW_odfX-Db8jAFd1FAzgJXcq0FRnMoYbLlZCgxizvMMn6zjN-c3dEk7x7_d9xO4J8Ef-zAfwN17rLe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1696689500</pqid></control><display><type>article</type><title>Combination of retrograde superselective intra-arterial chemotherapy and Seldinger method in locally advanced oral cancer</title><source>Publicly Available Content Database</source><source>IngentaConnect Journals</source><creator>Uehara, Masataka ; Ohya, Ryouichi ; Kodama, Masaaki ; Shiraishi, Takeshi ; Asahina, Izumi ; Tominaga, Kazuhiro</creator><creatorcontrib>Uehara, Masataka ; Ohya, Ryouichi ; Kodama, Masaaki ; Shiraishi, Takeshi ; Asahina, Izumi ; Tominaga, Kazuhiro</creatorcontrib><description>The nonsurgical strategies for locally advanced oral cancer are desirable. Superselective intra-arterial infusion with radiotherapy was utilized for this purpose, and there are two types of superselective intra-arterial infusion methods: The Seldinger method and the retrograde superselective intra-arterial chemotherapy (HFT method). In one case, the HFT method was applied to locally advanced tongue cancer, and the Seldinger method was used for additional administration of cisplatin (CDDP) to compensate for a lack of drug flow in the HFT method. In another case, the HFT method was applied to locally advanced lower gingival cancer. The Seldinger method was applied to metastatic lymph nodes. In both cases, additional administration of CDDP using the Seldinger method resulted in a complete response. The combination of the HFT and Seldinger methods was useful to eradicate locally advanced oral cancer because each method compensated for the defects of the other.</description><identifier>ISSN: 0973-1482</identifier><identifier>EISSN: 1998-4138</identifier><identifier>DOI: 10.4103/0973-1482.140833</identifier><identifier>PMID: 26148622</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Aged ; Analysis ; Antineoplastic Agents - administration &amp; dosage ; Carcinoma, Squamous Cell - drug therapy ; Carcinoma, Squamous Cell - radiotherapy ; Catheters ; Chemotherapy ; Chemotherapy, Adjuvant - methods ; Cisplatin - administration &amp; dosage ; Drug therapy ; Female ; Health aspects ; Humans ; Infusions, Intra-Arterial - methods ; Lymph Nodes - drug effects ; Lymph Nodes - radiation effects ; Lymphatic Metastasis - radiotherapy ; Lymphatic system ; Methods ; Middle Aged ; Mouth cancer ; Mouth Neoplasms - drug therapy ; Mouth Neoplasms - radiotherapy ; Veins &amp; arteries</subject><ispartof>Journal of cancer research and therapeutics, 2015-04, Vol.11 (2), p.475-478</ispartof><rights>COPYRIGHT 2015 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt Ltd Apr-Jun 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1696689500?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25752,27923,27924,37011,37012,44589</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26148622$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uehara, Masataka</creatorcontrib><creatorcontrib>Ohya, Ryouichi</creatorcontrib><creatorcontrib>Kodama, Masaaki</creatorcontrib><creatorcontrib>Shiraishi, Takeshi</creatorcontrib><creatorcontrib>Asahina, Izumi</creatorcontrib><creatorcontrib>Tominaga, Kazuhiro</creatorcontrib><title>Combination of retrograde superselective intra-arterial chemotherapy and Seldinger method in locally advanced oral cancer</title><title>Journal of cancer research and therapeutics</title><addtitle>J Cancer Res Ther</addtitle><description>The nonsurgical strategies for locally advanced oral cancer are desirable. Superselective intra-arterial infusion with radiotherapy was utilized for this purpose, and there are two types of superselective intra-arterial infusion methods: The Seldinger method and the retrograde superselective intra-arterial chemotherapy (HFT method). In one case, the HFT method was applied to locally advanced tongue cancer, and the Seldinger method was used for additional administration of cisplatin (CDDP) to compensate for a lack of drug flow in the HFT method. In another case, the HFT method was applied to locally advanced lower gingival cancer. The Seldinger method was applied to metastatic lymph nodes. In both cases, additional administration of CDDP using the Seldinger method resulted in a complete response. The combination of the HFT and Seldinger methods was useful to eradicate locally advanced oral cancer because each method compensated for the defects of the other.</description><subject>Aged</subject><subject>Analysis</subject><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Carcinoma, Squamous Cell - drug therapy</subject><subject>Carcinoma, Squamous Cell - radiotherapy</subject><subject>Catheters</subject><subject>Chemotherapy</subject><subject>Chemotherapy, Adjuvant - methods</subject><subject>Cisplatin - administration &amp; dosage</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Infusions, Intra-Arterial - methods</subject><subject>Lymph Nodes - drug effects</subject><subject>Lymph Nodes - radiation effects</subject><subject>Lymphatic Metastasis - radiotherapy</subject><subject>Lymphatic system</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Mouth cancer</subject><subject>Mouth Neoplasms - drug therapy</subject><subject>Mouth Neoplasms - radiotherapy</subject><subject>Veins &amp; arteries</subject><issn>0973-1482</issn><issn>1998-4138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkk2LHCEQhiUkZCeb3HMKQi659MSvtvW4DJsPWMghyVkcrZ5xsXWiPQvz72Mzmw0Jg4JS9byFVr0IvaVkLSjhH4keeEeFYmsqiOL8GVpRrVUnKFfP0eopfYVe1XpPSD8wpl6iKyZbVDK2QqdNnrYh2TnkhPOIC8wl74r1gOvxAKVCBDeHB8AhzcV2tsxQgo3Y7WHK8x6KPZywTR5_h-hD2kHBE8z77JsAx-xsjC3vH2xy4HEui3S5l9foxWhjhTeP5zX6-en2x-ZLd_ft89fNzV3nBBvmjirRb4WinDNHBBNec0a15b3bDsDtwHoiKdhx7CmMVilHpZSeEs_0sGx-jT6c6x5K_nWEOpspVAcx2gT5WA2VWmhJJe0b-v4_9D4fS2qvWygple4J-UvtbAQT0phbY9xS1NwIRnutek4b1V2gdpBax2JOMIYW_odfX-Db8jAFd1FAzgJXcq0FRnMoYbLlZCgxizvMMn6zjN-c3dEk7x7_d9xO4J8Ef-zAfwN17rLe</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Uehara, Masataka</creator><creator>Ohya, Ryouichi</creator><creator>Kodama, Masaaki</creator><creator>Shiraishi, Takeshi</creator><creator>Asahina, Izumi</creator><creator>Tominaga, Kazuhiro</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20150401</creationdate><title>Combination of retrograde superselective intra-arterial chemotherapy and Seldinger method in locally advanced oral cancer</title><author>Uehara, Masataka ; Ohya, Ryouichi ; Kodama, Masaaki ; Shiraishi, Takeshi ; Asahina, Izumi ; Tominaga, Kazuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-1845b481332c0424d93219a35cb7e3a725061eaff51efa88c1666d10d29729723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Analysis</topic><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Carcinoma, Squamous Cell - drug therapy</topic><topic>Carcinoma, Squamous Cell - radiotherapy</topic><topic>Catheters</topic><topic>Chemotherapy</topic><topic>Chemotherapy, Adjuvant - methods</topic><topic>Cisplatin - administration &amp; dosage</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Infusions, Intra-Arterial - methods</topic><topic>Lymph Nodes - drug effects</topic><topic>Lymph Nodes - radiation effects</topic><topic>Lymphatic Metastasis - radiotherapy</topic><topic>Lymphatic system</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Mouth cancer</topic><topic>Mouth Neoplasms - drug therapy</topic><topic>Mouth Neoplasms - radiotherapy</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uehara, Masataka</creatorcontrib><creatorcontrib>Ohya, Ryouichi</creatorcontrib><creatorcontrib>Kodama, Masaaki</creatorcontrib><creatorcontrib>Shiraishi, Takeshi</creatorcontrib><creatorcontrib>Asahina, Izumi</creatorcontrib><creatorcontrib>Tominaga, Kazuhiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cancer research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uehara, Masataka</au><au>Ohya, Ryouichi</au><au>Kodama, Masaaki</au><au>Shiraishi, Takeshi</au><au>Asahina, Izumi</au><au>Tominaga, Kazuhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combination of retrograde superselective intra-arterial chemotherapy and Seldinger method in locally advanced oral cancer</atitle><jtitle>Journal of cancer research and therapeutics</jtitle><addtitle>J Cancer Res Ther</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>11</volume><issue>2</issue><spage>475</spage><epage>478</epage><pages>475-478</pages><issn>0973-1482</issn><eissn>1998-4138</eissn><abstract>The nonsurgical strategies for locally advanced oral cancer are desirable. Superselective intra-arterial infusion with radiotherapy was utilized for this purpose, and there are two types of superselective intra-arterial infusion methods: The Seldinger method and the retrograde superselective intra-arterial chemotherapy (HFT method). In one case, the HFT method was applied to locally advanced tongue cancer, and the Seldinger method was used for additional administration of cisplatin (CDDP) to compensate for a lack of drug flow in the HFT method. In another case, the HFT method was applied to locally advanced lower gingival cancer. The Seldinger method was applied to metastatic lymph nodes. In both cases, additional administration of CDDP using the Seldinger method resulted in a complete response. The combination of the HFT and Seldinger methods was useful to eradicate locally advanced oral cancer because each method compensated for the defects of the other.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>26148622</pmid><doi>10.4103/0973-1482.140833</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0973-1482
ispartof Journal of cancer research and therapeutics, 2015-04, Vol.11 (2), p.475-478
issn 0973-1482
1998-4138
language eng
recordid cdi_proquest_miscellaneous_1694961615
source Publicly Available Content Database; IngentaConnect Journals
subjects Aged
Analysis
Antineoplastic Agents - administration & dosage
Carcinoma, Squamous Cell - drug therapy
Carcinoma, Squamous Cell - radiotherapy
Catheters
Chemotherapy
Chemotherapy, Adjuvant - methods
Cisplatin - administration & dosage
Drug therapy
Female
Health aspects
Humans
Infusions, Intra-Arterial - methods
Lymph Nodes - drug effects
Lymph Nodes - radiation effects
Lymphatic Metastasis - radiotherapy
Lymphatic system
Methods
Middle Aged
Mouth cancer
Mouth Neoplasms - drug therapy
Mouth Neoplasms - radiotherapy
Veins & arteries
title Combination of retrograde superselective intra-arterial chemotherapy and Seldinger method in locally advanced oral cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A42%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combination%20of%20retrograde%20superselective%20intra-arterial%20chemotherapy%20and%20Seldinger%20method%20in%20locally%20advanced%20oral%20cancer&rft.jtitle=Journal%20of%20cancer%20research%20and%20therapeutics&rft.au=Uehara,%20Masataka&rft.date=2015-04-01&rft.volume=11&rft.issue=2&rft.spage=475&rft.epage=478&rft.pages=475-478&rft.issn=0973-1482&rft.eissn=1998-4138&rft_id=info:doi/10.4103/0973-1482.140833&rft_dat=%3Cgale_proqu%3EA421598531%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c427t-1845b481332c0424d93219a35cb7e3a725061eaff51efa88c1666d10d29729723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1696689500&rft_id=info:pmid/26148622&rft_galeid=A421598531&rfr_iscdi=true